Form 4: CalciMedica Executive Eric W. Roberts Increases Stake in Company

Eric W. Roberts, Chief Business Officer of CalciMedica, recently acquired additional shares of the company's common stock through multiple transactions.

Summary

• Eric W. Roberts, the Chief Business Officer of CalciMedica, has reported changes in his beneficial ownership of the company's stock.
• On August 23, 2024, Roberts acquired 2,000 shares of common stock at a price of $3.5785 per share and 3,000 shares at $3.57 per share.
• These purchases were made indirectly through Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA and FMTC Custodian Roth IRA FBO Eric W. Roberts.
• Following these transactions, Roberts directly owns 111,373 shares of common stock.
• He also indirectly owns shares through various entities, including 46,894 shares through Oppenheimer & Co Inc., 13,223 shares through FMTC Custodian, 10,661 shares through IRA Financial Trust Company, 356,989 shares through Valence Investments SPV IV, LLC, 66,228 shares through Valence Investments SPV V, LLC, and 316,109 shares through Valence Investments SPV VI, LLC.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but the increased stake could be seen as mildly positive.

Positives

• The increased stake by a key executive could be interpreted as a positive signal about the company's prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking insights into management's confidence in the company.

Stakeholder Impact

• Shareholders may view the increased stake by the Chief Business Officer as a positive sign.

Key Dates